In the first three quarters of this year, the import and export volume of Chinese medicine was 3.761 billion U.S. dollars, up by 7.40% over the same period of 2006. Of this total, exports were 2.6 billion U.S. dollars, down 0.27% year-on-year; the import was 1.166 billion U.S. dollars, up 30.81% year-on-year.
Among the commodities exports, Chinese Herbal Pieces showed more eye-catching export performance, with a significant increase of 49.68% in export volume but a slight increase in export value. Export performance has been very good for plant extracts with a slight decrease year-on-year year on year Big.
The United States jumped to China's largest export market of Chinese medicine
In the first three quarters, China's traditional Chinese medicines were exported to 118 countries and regions, of which the Asian region is both a traditional market and a major market for Chinese traditional medicine exports: the first three quarters of exports to Asian countries and regions were 1.5 billion U.S. dollars, down 0.06% , Accounting for 57.73%.
The United States used to be the second or third largest market for Chinese medicine exports and maintained a relatively high growth rate in the past two years. In the first three quarters of 2017, the United States surpassed Japan to overtake Japan's largest export market for Chinese medicine. The first three quarters Its exports to the United States reached 425 million U.S. dollars, accounting for 16.36% of the total exports of Chinese medicine. The exports of raw materials of Chinese herbal medicines and health products increased greatly year on year.
The first three quarters of China's exports to the Japanese market, medicine, an increase of 36.40%, exports 370 million US dollars, up slightly by 3.35%. Japan's exports are mainly plant extracts and Chinese herbal medicine Pieces, including plant extracts in terms of quantity Or the amount of exports have a certain increase over the same period last year.
China's Hong Kong continued to be the third largest market for mainland Chinese medicine exports, with exports of 340 million U.S. dollars in the first three quarters, down 15.30% on a year-on-year basis.
The first three quarters of China's exports of Korean medicine to 1.5 billion US dollars, down 13.47%, accounting for 5.85% of China's exports of Chinese medicine exports to South Korea are mainly plant extracts and Chinese herbal medicine Pieces, the two exports amounted to 73,394,500 US dollars, Down 20.63% from a year earlier.
China exported 444 million U.S. dollars of Chinese medicine to Europe in the first three quarters, down slightly by 1.66% year-on-year, accounting for 17.10% of the total exports of Chinese medicine. The main plant extracts from Europe accounted for 71.99% of the total exports of Chinese medicine. The major export markets are Germany Spain and France.
The EU is one of the largest botanical drug markets in the world and one of the major target markets for exports of proprietary Chinese medicines in recent years. In recent years, the registration of traditional Chinese medicines in the EU has become a hot topic in the Chinese medicine industry and has also become a fetter for selling traditional Chinese medicines as a pharmaceutical product in the EU. Since the implementation of Directive 2004/24 / EC, the export of proprietary Chinese medicines to the EU has been on the decline, but in the first three quarters of this year, China's export of proprietary Chinese medicines to the 15 EU countries was realized US $ 5,005,300, an increase of 8.73% over the same period of last year, while exports to the EU with a total of 12 countries eastward expanded by 3.5596 million US dollars, up 3.59% over the same period of last year.
Cordyceps exports to Hong Kong have picked up
With regard to various varieties and plant extracts, the United States has replaced Japan as the largest export market for plant extracts in China since 2011. The US plant extracts are mainly used for the production of dietary supplements and food additives, and the demand has been relatively strong. China's plant extracts exported to Japan are mainly used as raw materials for Japanese Kampo medicines and plant extracts exported to South Korea are mainly used as raw materials for health care products and cosmetics.
It is noteworthy that Hong Kong has also been the major export market for Cordyceps sinensis in the Mainland, but with the continuous rise in export prices, Cordyceps exports to Hong Kong dropped sharply, Cordyceps exports in 2013 reached 29348.34 US dollars / kg, up 16.07%, exports shrank to 305 kg, down 57.7%. By 2015, the mainland of Cordyceps exports to Hong Kong has risen somewhat, the export price is relatively stable. In the third quarter, the export volume of Cordyceps sinensis in Hong Kong was 469 kg, the export price was 22,506.55 USD / kg, an increase of 18.56% over the same period of last year.
China's exports of health products have been mainly raw materials, the lack of high value-added health care products. The United States and Japan have been the main market for the export of health products in China, of which more than 55% of China's exports of health products are fish oil products; Exports of health care products to Japan are mainly royal jelly products, accounting for about 90% of China's exports of health products to Japan in recent years, China's royal jelly international standard-setting work has made a breakthrough, and promote the development of our royal jelly industry, quality supervision , Scientific research and so on, so that our country in the field of international price dominance increased.
Some varieties of import and export trade fluctuations
The first three quarters of 2017, China's bird's nest imports of 48,341 kg, an increase of 84.89%, the import price of 1683.43 US dollars / kg, up 12.88% over the same period last year, mainly due to the surge in imports of domestic bird's nest products in the big data Ali " 2017 China New Year big data report ", bird's nest in the Hot Local Products ranked fifth.
In the first three quarters of 2017, the import of antler in our country was 485,861 kg, an increase of 22.88% over the same period of last year. The import price was 58.63 USD / kg, up by 221.30% over the same period of last year. Import of 98.30% of China's antler was from New Zealand.
In the first three quarters of 2017, China's ginseng exports were 1,177,909 kg, down 18.36% from the same period of last year while the export price was 50.04 USD / kg, down 31.87% from the same period of last year. The main reason for the decline in exports of ginseng in China was the weaker demand in Japan and Europe.
